
    
      Intervention: At randomization eligible patients were allocated to receive 2.5ml of isotonic
      magnesium sulphate (150 mg,245 mmol/L) on three occasional at 20 minutes interval or standard
      treatment 50 mg/kg intravenous magnesium sulphate. The asthma severity score was record at
      0,20,40,60,120,180,240 minutes post randomization. Adverse event were assessed at each
      assessment point. Patients were followed up until discharge from hospital to collect
      secondary outcome data.
    
  